The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Hepatitis C Virus Infection in A Community in the Nile Delta: Risk Factors for Seropositivity
Abstract
The purpose of this study was to identify risk factors for hepatitis C virus (HCV) infection in a rural village in the Nile Delta with a high prevalence of antibodies to HCV (anti–HCV). One half of the village households were systematically selected, tested for anti–HCV, and interviewed: 973 of 3,999 (24.3%) subjects were anti–HCV–positive (reflecting prior HCV infection but not necessarily current liver disease), with nearly equal prevalence among males and females. Anti–HCV prevalence increased sharply with age among both males and females, from 9.3% in those 20 years of age and younger to >50% in those older than 35, suggesting a cohort effect with reduced transmission in recent years. Multivariate regression was used to estimate independent effects of risk factors on seropositivity. Among those over 20 years of age, the following risk factors were significantly associated with seropositivity: age (P < .001); male gender (odds ratio [OR] = 2.5, 95% CI = 1.3–4.7); marriage (OR = 4.1, 2.4–6.9); anti–schistosomiasis injection treatment (OR = 2.0, 1.3–2.9); blood transfusion (OR = 1.8, 1.1–2.9), invasive medical procedure (surgery, catheterization, endoscopy, and/or dialysis) (OR = 1.5, 1.1–1.9); receipt of injections from “informal” health care provider (OR = 1.3, 1.0–1.6); and cesarean section or abortion (OR = 1.4, 1.0–1.9). Exposures not significantly related to anti–HCV positivity in adults included: history of, or active infection with, Schistosoma mansoni, sutures or abscess drainage, goza smoking in a group, and shaving by community barbers. Among those 20 years old or younger, no risk factors were clearly associated with anti–HCV positivity; however, circumcision for boys by informal health care providers was marginally associated with anti–HCV (OR = 1.7, 1.0–3.0). Prevention programs focused primarily on culturally influenced risks in rural Egyptian communities are being implemented and evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Self-citationAlter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Guadagnino, V, Stroffolini, T., Rapicetta, M., Costantino, A., Kondili, L. A., Menniti-Ippolito, F., Caroleo, B., Costa, C., Griffo, G., Loiacono, L., et al. (1997) · Hepatology · doi:10.1002/hep.510260431 · Cited by 389
Abdel-Aziz, F., Habib, M., Mohamed, M. K., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Thomas, D., Fix, A. D., Strickland, T. G., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8438 · Cited by 265
Self-citationHepatitis C virus infection in the United States
Alter, M. J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80381-x · Cited by 235
Darwish, M. A., Raouf, T. A., Rushdy, P., Constantine, N. T., Rao, M. R., & Edelman, R. (1993) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.49.440 · Cited by 172
Hepatitis C Virus Infection in Spouses of Patients with Type C Chronic Liver Disease
Akahane, Y., Kojima, M., Sugai, Y., Sakamoto, M., Miyazaki, Y., Tanaka, T., Tsuda, F., Mishiro, S., Okamoto, H., Miyakawa, Y., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00005 · Cited by 167
Sun, C., Chen, H., Lu, C., You, S., Mau, Y., Ho, M., Lin, S., & Chen, C. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199911)59:3<290::aid-jmv5>3.0.co;2-r · Cited by 155
High Seroprevalence of Hepatitis C Infection among Risk Groups in Egypt
Abdel-Wahab, M. F., Zakaria, S., Kamel, M., Abdel-Khaliq, M. K., Mabrouk, M., Salama, H., Esmat, G., Thomas, D. L., & Strickland, G. T. (1994) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.563 · Cited by 141
Cited by
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
The effects of waterpipe tobacco smoking on health outcomes: a systematic review
Akl, E. A., Gaddam, S., Gunukula, S. K., Honeine, R., Jaoude, P. A., & Irani, J. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq002 · Cited by 624
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis
Mohamoud, Y. A., Mumtaz, G. R., Riome, S., Miller, D., & Abu-Raddad, L. J. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-288 · Cited by 413
Akl, E. A., Gunukula, S. K., Aleem, S., Obeid, R., Jaoude, P. A., Honeine, R., & Irani, J. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-244 · Cited by 393
Health effects associated with waterpipe smoking
El-Zaatari, Z. M., Chami, H. A., & Zaatari, G. S. (2015) · Tobacco Control · doi:10.1136/tobaccocontrol-2014-051908 · Cited by 343
Hepatitis C genotype 4: What we know and what we don't yet know†
Kamal, S. M., & Nasser, I. A. (2008) · Hepatology · doi:10.1002/hep.22127 · Cited by 301
Kandeel, A., Genedy, M., El‐Refai, S., Funk, A. L., Fontanet, A., & Talaat, M. (2017) · Liver International · doi:10.1111/liv.13186 · Cited by 283
Screening and Treatment Program to Eliminate Hepatitis C in Egypt
Waked, I., Esmat, G., Elsharkawy, A., El-Serafy, M., Abdel-Razek, W., Ghalab, R., Elshishiney, G., Salah, A., Abdel Megid, S., Kabil, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr1912628 · Cited by 282
Strickland, T. G. (2006) · Hepatology · doi:10.1002/hep.21173 · Cited by 272
Self-citationWaziry, R., Jawad, M., Ballout, R. A., Al Akel, M., & Akl, E. A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw021 · Cited by 263
Pybus, O. G. (2003) · Molecular Biology and Evolution · doi:10.1093/molbev/msg043 · Cited by 246
“Egypt has possibly the highest HCV prevalence in the world; 10%–20% of the general population are infected and HCV is the leading cause of HCC and chronic liver disease in the country (Arthur et al. 1997; Nafeh et al. 2000; El-Zayadi et al. 2001; Habib et al. 2001; Hassan et al. 2001).”
Background
Metadata
- Authors
- Habib, M., Mohamed, M. K., Abdel-Aziz, F., Magder, L. S., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Anwar, W., Strickland, T. G., Fix, A. D., & Sallam, I.
- Venue
- Hepatology
- Published
- 2001-01
- Volume
- 33
- Issue
- 1
- Pages
- 248-253
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2111873529
- Cited by
- 295
- References
- 24
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.